Dr. Jonathan Mark Vapnek, MD
- Medicare services, 2024
- 7,434
- Medicare patients, 2024
- 937
- Part D claims, 2024
- 3,589
- Industry payments
- $34,820
- Affiliated sites
- 1
- Practice address
- 229 E 79th St, New York, NY 10075-0866
- Practice phone
- Call (212) 717-9500
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Jonathan Vapnek, MD
Physician office · New York, New York
Find Dr. Vapnek's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Jonathan Mark Vapnek is a urologist in New York, New York
Dr. Vapnek practices at Jonathan Vapnek, MD in New York, New York.
Dr. Vapnek's NPI, 1558367771, was assigned on June 22, 2005. Dr. Vapnek graduated from University of California San Diego School of Medicine in 1986. Dr. Vapnek holds New York license 192313.
- NPI
- 1558367771NPI Registry (opens in a new tab)
- Medicare PAC ID
- 4385694447
- NPI enumeration date
- June 22, 2005
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (212) 717-9500
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 66
- Medical school graduation
- 1986
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Jonathan Mark Vapnek practices at Jonathan Vapnek, MD in New York, New York
Dr. Vapnek's primary practice is Jonathan Vapnek, MD, at 229 E 79th St, New York, NY 10075-0866. The practice phone is (212) 717-9500.
- Jonathan Vapnek, MD229 E 79th St, New York, NY 10075-0866Phone(212) 717-9500
Source: Dmand AI Affiliation Data
Dr. Jonathan Mark Vapnek is affiliated with 1 site of care
Dr. Vapnek's primary practice is Jonathan Vapnek, MD in New York, New York.
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Jonathan Mark Vapnek's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vapnek practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Jonathan Vapnek, MD | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Jonathan Mark Vapnek is one of 919 urologists in New York
Urology is Dr. Vapnek's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Vapnek is licensed in New York.
Specialties and state licenses
- Urology, New YorkPrimary
Urologists near Dr. Vapnek
Counts of urologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Jonathan Mark Vapnek billed Medicare for 7,434 services in 2024
CMS data shows 7,434 Medicare services from Dr. Vapnek across 19 procedure codes in 2024, for 937 Medicare patients. Medicare paid $231,827 for them. Every service was in an office.
Dr. Vapnek's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 1,7012024: 2,20029%
- Office and hospital visits
- 2023: 1,9612024: 1,9901%
- Surgery
- 2023: 1,8592024: 1,867No change
- Lab and pathology
- 2023: 1,2682024: 1,2892%
- Imaging
- 2023: 1012024: 8813%
- Tests and treatments
- 2023: 182024: 0100%
Dr. Vapnek compared with the New York median for urologists, 2024
- Dr. Vapnek
- New York median
- Medicare services
- 7,434vs 8498.8 times
- Medicare patients
- 937vs 3602.6 times
- Part D claims
- 3,436vs 5895.8 times
Medians across 885 urologists in New York with Dmand AI profiles that report each measure.
Dr. Vapnek's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Vapnek?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Vapnek and other urologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Jonathan Mark Vapnek treated 937 Medicare patients in 2024, average age 77
CMS counts 937 Medicare patients who saw Dr. Vapnek in 2024. The largest group is 75 to 84, with 408 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Vapnek's median patient age at 67, with 17% women.
Dr. Vapnek's Medicare patients by age, 2024
Dr. Vapnek's Medicare patients by sex, 2024
- Women24426%
- Men69374%
Chronic conditions among Dr. Vapnek's Medicare patients, 2024
- High cholesterol75%
- High blood pressure67%
- Arthritis52%
- Ischemic heart disease37%
- Diabetes29%
- Anxiety23%
- Mood disorders22%
- Cancer19%
Share of Medicare patients with each condition. A patient can have several.
Dr. Vapnek's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 67
Patient panel by sex, all payers
- Women17%
- Men78%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Jonathan Mark Vapnek wrote 3,589 Medicare Part D claims in 2024
In 2024, Dr. Vapnek wrote 3,589 Medicare Part D claims for 681 patients. 89% of them were for generic drugs. CMS names the drug for 3,436 of them, across 39 drugs with 11 or more claims each, at $324,293 in total drug cost. In 2023, CMS named 3,298 claims across 37 drugs.
Dr. Vapnek's Part D claims by kind of drug, 2024
- Generic3,205 claims89%
- Brand-name384 claims11%
Dr. Vapnek's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Vapnek's Part D claims, 2024
- Opioids1%23 of 3,589 claims
- Antibiotics17%604 of 3,589 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 3,2982024: 3,4364%
Drugs named by CMS: 39 in 2024, 37 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Jonathan Mark Vapnek scored 0 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Dr. Vapnek for performance year 2024, reported individually. Dr. Vapnek accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vapnek as offering telehealth. CMS counts 11 procedures of removal of skin lesions by Dr. Vapnek, more than 58% of the clinicians it reports for that procedure.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Vapnek's MIPS scores, performance year 2024
- 0of 100Final score
- 0of 100Quality
- 0of 100Improvement Activities
- 0of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Where Dr. Vapnek ranks in Medicare procedure volume
- Removal of skin lesions
- 58th percentile11 procedures
CMS ranks each clinician against every clinician it reports for the same procedure category.
Sources: Doctors and Clinicians National Downloadable File (CMS); Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026; and Doctors and Clinicians Utilization Data (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Jonathan Mark Vapnek received $34,820 in industry payments from 2016 to 2025
CMS Open Payments shows 368 general payments to Dr. Vapnek from 39 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 68% of the total. Astellas Pharma US Inc paid the most, $23,253.
General payments to Dr. Vapnek by program year, 2016 to 2025
General payments to Dr. Vapnek by kind, 2016 to 2025
- Speaker and faculty fees$23,57568%
- Food and beverage$9,58728%
- Travel and lodging$5952%
- Education$5642%
- Grants$5001%
Companies that paid Dr. Vapnek the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Jonathan Mark Vapnek graduated from University of California San Diego School of Medicine
Dr. Vapnek graduated from University of California San Diego School of Medicine in 1986.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Jonathan Mark Vapnek's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Jonathan Mark Vapnek
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Jonathan Mark Vapnek's NPI number?
Dr. Jonathan Mark Vapnek's NPI number is 1558367771. It was assigned on June 22, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Jonathan Mark Vapnek?
Dr. Jonathan Mark Vapnek is a urologist in New York, New York. The primary specialty in the NPI Registry is Urology Physician (taxonomy code 208800000X).
Where does Dr. Jonathan Mark Vapnek practice?
Dr. Vapnek practices at 229 E 79th St, New York, NY 10075-0866. Dr. Vapnek's primary practice is Jonathan Vapnek, MD in New York, New York.
What is Dr. Jonathan Mark Vapnek's office phone number?
The practice phone on file for Dr. Vapnek is (212) 717-9500.
What is Dr. Jonathan Mark Vapnek's medical license number?
Dr. Vapnek holds New York license 192313.
Does Dr. Jonathan Mark Vapnek accept Medicare?
Yes. CMS data shows Dr. Vapnek billed Medicare for 7,434 services in 2024, and Dr. Vapnek accepts Medicare assignment.
Does Dr. Jonathan Mark Vapnek offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Vapnek as offering telehealth services.
What is Dr. Jonathan Mark Vapnek's MIPS score?
Dr. Vapnek's MIPS final score for performance year 2024 is 0 out of 100, reported individually.
How many Medicare patients does Dr. Jonathan Mark Vapnek see?
CMS counts 937 Medicare patients who saw Dr. Vapnek in 2024, with an average age of 77.
What services does Dr. Jonathan Mark Vapnek bill to Medicare?
In 2024, Dr. Vapnek's most billed Medicare services were injected or infused drug (J0585), lab and pathology test (81000) and surgery: urinary system (51798).
Show 4 more questionsShow fewer questions
Where did Dr. Jonathan Mark Vapnek go to medical school?
Dr. Vapnek graduated from University of California San Diego School of Medicine in 1986.
What drugs does Dr. Jonathan Mark Vapnek prescribe most?
In 2024 Medicare Part D data, Dr. Vapnek's most prescribed drugs by claims were Tamsulosin HCl, Finasteride and Oxybutynin Chloride ER.
Has Dr. Jonathan Mark Vapnek received payments from drug or device companies?
CMS Open Payments shows $34,820 in general payments to Dr. Vapnek from 39 companies from 2016 to 2025. The largest total came from Astellas Pharma US Inc.
How long has Dr. Jonathan Mark Vapnek been practicing?
Dr. Vapnek graduated from medical school in 1986, 40 years ago.
Selling to urology practices?
See urologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card